Continuous coverage unwinding
Jun. 2023Important Notices
The continuous coverage unwinding period began on April 1. Medicaid recipients may have questions about their Medicaid eligibility determination.
We developed this FAQ to help you educate patients who have already submitted their renewal.
The goal of this material is to:
We developed this FAQ to help you educate patients who have already submitted their renewal.
The goal of this material is to:
- Help patients understand the Medicaid renewal process and have them keep an eye out for mail from DHS.
- Provide guidance to patients who did not return required verification documents.
- Provide guidance to patients who received a coverage termination letter.
- UPMC for You Continuous Coverage Postcard
- UPMC for You Continuous Coverage Postcard Spanish
- UPMC Community HealthChoices Participant Postcard
- UPMC Community HealthChoices Participant Postcard Spanish
In addition to the FAQ, the items below may be distributed to your UPMC for You patients and UPMC Community HealthChoices participants. These materials can be ordered through MarketingExpress, which is available via Provider OnLine.
Instructions on how to use MarketingExpress are also available. If you have any questions, please contact your physician account executive or call Provider Services at 1-866-918-1595.
Recent Announcements
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Sep. 2026Education/Webinars
Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)
Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).Sep. 2026Pharmacy Updates
Voluntary nationwide recall: Dextrose (Baxter – August 2026)
Baxter International Inc. is recalling one lot (lot Y495066) of 70% Dextrose Injection. Dextrose is used to replenish calories and fluid in certain situations.Sep. 2026Pharmacy Updates